
North America Stroke Post Processing Software Market Size, Share & Trends Analysis Report By Installation, By Modality (MRI, and CT Scan), By Type, By End-use, By Country and Growth Forecast, 2024 - 2031
Description
The North America Stroke Post Processing Software Market would witness market growth of 8.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America Stroke Post Processing Software Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $102,186.4 Thousands by 2031. The Canada market is experiencing a CAGR of 10.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10% during (2024 - 2031).
This market has emerged as a critical segment within the broader healthcare technology landscape, driven by the urgent need to address the burden of stroke—a leading cause of death and disability. As medical science advances and technology integration in healthcare deepens, this software has become an indispensable tool for clinicians, radiologists, and neurologists.
This software leverages sophisticated algorithms, artificial intelligence (AI), and machine learning (ML) to analyze medical imaging data, enabling faster, more accurate diagnoses and improved treatment planning for stroke patients. With the rising incidence of stroke, fuelled by aging populations, sedentary lifestyles, and increasing prevalence of risk factors such as hypertension and diabetes, the demand for advanced diagnostic and management tools has surged.
The Government of Canada’s $196.1 billion healthcare investment over ten years, including $46.2 billion in new funding, aims to enhance healthcare services, strengthen hospital infrastructure, and promote digital healthcare solutions. Additionally, the $2.5 billion investment to support Indigenous healthcare priorities underscores the government’s commitment to expanding access to medical technologies. In the United States, stroke accounts for 1 in 6 deaths (17.5%) from cardiovascular disease, with a stroke occurring every 40 seconds and a stroke-related death happening every 3 minutes and 11 seconds. These alarming statistics highlight the urgent need for efficient stroke detection and post-processing solutions. In 2021, Mexico recorded approximately 226,000 deaths due to cardiovascular diseases, surpassing deaths from COVID-19. This highlights the critical need for better stroke detection, early intervention, and improved hospital infrastructure. The Mexican government increasingly prioritizes healthcare modernization, investing in digital diagnostics, AI-powered stroke imaging, and cloud-based radiology solutions. In conclusion, the rising healthcare investments, high stroke prevalence, and increasing adoption of AI-driven imaging solutions in Canada, the United States, and Mexico are fuelling the demand for stroke post processing software.
Based on Installation, the market is segmented into Desktop, and Mobile Phones & Tablets. Based on Modality, the market is segmented into MRI, and CT Scan. Based on Type, the market is segmented into Ischemic Stroke, Hemorrhagic Stroke, and Other Type. Based on End-use, the market is segmented into Hospitals & Clinics, and Specialty Centers & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
By Installation
The US market dominated the North America Stroke Post Processing Software Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $102,186.4 Thousands by 2031. The Canada market is experiencing a CAGR of 10.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10% during (2024 - 2031).
This market has emerged as a critical segment within the broader healthcare technology landscape, driven by the urgent need to address the burden of stroke—a leading cause of death and disability. As medical science advances and technology integration in healthcare deepens, this software has become an indispensable tool for clinicians, radiologists, and neurologists.
This software leverages sophisticated algorithms, artificial intelligence (AI), and machine learning (ML) to analyze medical imaging data, enabling faster, more accurate diagnoses and improved treatment planning for stroke patients. With the rising incidence of stroke, fuelled by aging populations, sedentary lifestyles, and increasing prevalence of risk factors such as hypertension and diabetes, the demand for advanced diagnostic and management tools has surged.
The Government of Canada’s $196.1 billion healthcare investment over ten years, including $46.2 billion in new funding, aims to enhance healthcare services, strengthen hospital infrastructure, and promote digital healthcare solutions. Additionally, the $2.5 billion investment to support Indigenous healthcare priorities underscores the government’s commitment to expanding access to medical technologies. In the United States, stroke accounts for 1 in 6 deaths (17.5%) from cardiovascular disease, with a stroke occurring every 40 seconds and a stroke-related death happening every 3 minutes and 11 seconds. These alarming statistics highlight the urgent need for efficient stroke detection and post-processing solutions. In 2021, Mexico recorded approximately 226,000 deaths due to cardiovascular diseases, surpassing deaths from COVID-19. This highlights the critical need for better stroke detection, early intervention, and improved hospital infrastructure. The Mexican government increasingly prioritizes healthcare modernization, investing in digital diagnostics, AI-powered stroke imaging, and cloud-based radiology solutions. In conclusion, the rising healthcare investments, high stroke prevalence, and increasing adoption of AI-driven imaging solutions in Canada, the United States, and Mexico are fuelling the demand for stroke post processing software.
Based on Installation, the market is segmented into Desktop, and Mobile Phones & Tablets. Based on Modality, the market is segmented into MRI, and CT Scan. Based on Type, the market is segmented into Ischemic Stroke, Hemorrhagic Stroke, and Other Type. Based on End-use, the market is segmented into Hospitals & Clinics, and Specialty Centers & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Brainomix Limited
- Viz.ai, Inc.
- GE HealthCare Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Koninklijke Philips N.V.
- Canon, Inc. (Canon Medical Systems Corporation)
- Terarecon, Inc.
- Nicolab B.V.
- Medtronic PLC
- iSchemaView Inc. (RapidAI)
By Installation
- Desktop
- Mobile Phones & Tablets
- MRI
- CT Scan
- Ischemic Stroke
- Hemorrhagic Stroke
- Other Type
- Hospitals & Clinics
- Specialty Centers & Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
112 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Stroke Post Processing Software Market, by Installation
- 1.4.2 North America Stroke Post Processing Software Market, by Modality
- 1.4.3 North America Stroke Post Processing Software Market, by Type
- 1.4.4 North America Stroke Post Processing Software Market, by End-use
- 1.4.5 North America Stroke Post Processing Software Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis – Global
- 4.1 Market Share Analysis, 2023
- 4.2 Recent Strategies Deployed in Stroke Post Processing Software Market
- 4.3 Porter Five Forces Analysis
- Chapter 5. North America Stroke Post Processing Software Market by Installation
- 5.1 North America Desktop Market by Region
- 5.2 North America Mobile Phones & Tablets Market by Region
- Chapter 6. North America Stroke Post Processing Software Market by Modality
- 6.1 North America MRI Market by Country
- 6.2 North America CT Scan Market by Country
- Chapter 7. North America Stroke Post Processing Software Market by Type
- 7.1 North America Ischemic Stroke Market by Country
- 7.2 North America Hemorrhagic Stroke Market by Country
- 7.3 North America Other Type Market by Country
- Chapter 8. North America Stroke Post Processing Software Market by End-use
- 8.1 North America Hospitals & Clinics Market by Country
- 8.2 North America Specialty Centers & Others Market by Country
- Chapter 9. North America Stroke Post Processing Software Market by Country
- 9.1 US Stroke Post Processing Software Market
- 9.1.1 US Stroke Post Processing Software Market by Installation
- 9.1.2 US Stroke Post Processing Software Market by Modality
- 9.1.3 US Stroke Post Processing Software Market by Type
- 9.1.4 US Stroke Post Processing Software Market by End-use
- 9.2 Canada Stroke Post Processing Software Market
- 9.2.1 Canada Stroke Post Processing Software Market by Installation
- 9.2.2 Canada Stroke Post Processing Software Market by Modality
- 9.2.3 Canada Stroke Post Processing Software Market by Type
- 9.2.4 Canada Stroke Post Processing Software Market by End-use
- 9.3 Mexico Stroke Post Processing Software Market
- 9.3.1 Mexico Stroke Post Processing Software Market by Installation
- 9.3.2 Mexico Stroke Post Processing Software Market by Modality
- 9.3.3 Mexico Stroke Post Processing Software Market by Type
- 9.3.4 Mexico Stroke Post Processing Software Market by End-use
- 9.4 Rest of North America Stroke Post Processing Software Market
- 9.4.1 Rest of North America Stroke Post Processing Software Market by Installation
- 9.4.2 Rest of North America Stroke Post Processing Software Market by Modality
- 9.4.3 Rest of North America Stroke Post Processing Software Market by Type
- 9.4.4 Rest of North America Stroke Post Processing Software Market by End-use
- Chapter 10. Company Profiles
- 10.1 Brainomix Limited
- 10.1.1 Company Overview
- 10.1.2 Recent strategies and developments:
- 10.1.2.1 Product Launches and Product Expansions:
- 10.2 Viz.ai, Inc.
- 10.2.1 Company Overview
- 10.2.2 Recent strategies and developments:
- 10.2.2.1 Partnerships, Collaborations, and Agreements:
- 10.3 GE HealthCare Technologies, Inc.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 SWOT Analysis
- 10.4 Siemens Healthineers AG (Siemens AG)
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 SWOT Analysis
- 10.5 Koninklijke Philips N.V.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Partnerships, Collaborations, and Agreements:
- 10.5.6 SWOT Analysis
- 10.6 Canon, Inc. (Canon Medical Systems Corporation)
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 SWOT Analysis
- 10.7 Terarecon, Inc.
- 10.7.1 Company Overview
- 10.8 Nicolab B.V.
- 10.8.1 Company Overview
- 10.9 Medtronic PLC
- 10.9.1 Company overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental and Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
- 10.10. iSchemaView Inc. (RapidAI)
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
- 10.10.2.1 Product Launches and Product Expansions:
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.